FASS logotyp

Peka på symbolerna och beteckningarna till vänster för en förklaring.


Sök apotek med läkemedlet i lager

Sök lagerstatus



Filmdragerad tablett 240 mg
(Gul, oval tablett, präglad med ”591”på den ena sidan och MSD-logotypen på den andra. Tabletten är 16,5 mm lång och 8,5 mm bred.)

Virushämmande medel för systemiskt bruk, direkt verkande virushämmande medel

Aktiv substans:
ATC-kod: J05AX18
Utbytbarhet: Ej utbytbar
Läkemedel från MSD omfattas av Läkemedelsförsäkringen.
  • Vad är miljöinformation?




Miljörisk: Användning av letermovir har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning: Letermovir bryts ned långsamt i miljön.
Bioackumulering: Letermovir har låg potential att bioackumuleras.

Läs mer

Detaljerad miljöinformation

Environmental Risk Classification

Predicted Environmental Concentration (PEC)

PEC is calculated according to the following formula:

PEC (μg/L) = (A*109 *(100-R))/(365*P*V*D*100) = 1.5*10-6 *A(100-R)

PEC = 0.015 μg/L


A = < 100 kg (maximum estimated 5 year sales in Sweden, data blinded for confidentiality)

R = 0 % removal rate (worst case assumption)

P = number of inhabitants in Sweden = 9 *106 

V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Ref. I)

D = factor for dilution of waste water by surface water flow = 10 (ECHA default) (Ref. I)

Predicted No Effect Concentration (PNEC)

Ecotoxicological studies

Green Algae (Pseudokirchneriella subcapitata) (OECD 201) (Reference II): 

EC50 72h > 8.8 mg/L

NOEC 72h = 8.8 mg/L

No effects noted for any endpoint (yield and growth rate)

Crustacean, water flea (Daphnia magna) (OECD 211) (Ref. III): 

Chronic toxicity

NOEC 21d = 1.2 mg/L (reproduction and length)

Fish, fathead minnow (Pimephales promelas) (OECD 210) (Ref. IV): 

Chronic toxicity

NOEC 32d = 1 mg/L

No effects noted for any endpoint (hatching, survival, growth)

PNEC = 100 μg/L (1 mg/ L/ 10 based on the most sensitive NOEC for the fathead minnow and an assessment factor (AF) of 10)

Environmental risk classification (PEC/PNEC ratio)

PEC/PNEC = 0.015 /100 = 0.00015, i.e. PEC/PNEC ≤ 0.1 which justifies the phrase "Use of letermovir has been considered to result in insignificant environmental risk.

Biotic degradation

Biodegradation in Activated Sludge

1% to CO2 in 28 days (OECD 314B) (Ref V)

DT50 = 6.7 days

[14C] letermovir was evaluated for biodegradability in wastewater according to OECD Guideline 314B. Activated sludge was dosed with approximately 1 mg/L [14C] letermovir. Mass balance of the biotic sludge system ranged from 94.0 to 99.2% of the applied radioactivity (% AR) over the course of the study. Ultimate biodegradation (conversion to CO2) occurred at 1% AR in the biotic activated sludge test solutions at day 28. Five regions of radioactivity were observed in the HPLC/RAM analyses of the biotic sludge in addition to the parent peak. Two metabolites M1 and M2 were measured in concentrations greater than 10% by Day 28 (identified in the OECD 308 study, below). The overall primary biodegradation half-life of letermovir in the biotic sludge was calculated to be 6.7 days. The elimination rate constant, ke, was 0.1028 days-1.


Sediment Transformation (OECD 308) (Ref. VI):

Ultimate degradation < 1%

DT50 (total system) = 22-34 days

Transformation of [14C] letermovir was also evaluated in two aerobic sediment/water systems at 20°C for 100 days following OECD Guideline 308. Sediment/water systems were dosed with 1 mg/L [14C] letermovir. Carbon dioxide (CO2) produced due to biodegradation was trapped and measured over the test period. Sediment and water samples were extracted and analyzed to determine extractable radioactivity. Average recovery ranged from 94.1 to 95.8% over the 100 day test period.

Ultimate biodegradation of [14C] letermovir was observed in the aerobic samples with evolution of 14CO2 reaching an average maximum of 0.303 and 0.328% AR for the Taunton River and Weweantic River aerobic test samples, respectively, at Day 100. Generation of volatile organic compounds was negligible and observed < LOQ for the Taunton River aerobic test samples and at an average maximum of 0.026% AR for the Weweantic River aerobic test samples at Day 100.


Evidence of primary biodegradation was observed for [14C] letermovir in the aerobic water/sediment test systems. Two major peaks (≥ 10% AR) were observed in some of the chromatograms for the Taunton River and Weweantic River samples (Met 1 and 7). Several minor peaks were observed in some of the chromatograms for the Taunton River and Weweantic River test samples. In all cases, these minor peaks represented less than 10% AR in the water and sediment extracts and were not characterized further.

Further degradation of Met 1 was not apparent. Percentages in the total system continued to increase or remain constant through Day 100. For Met 7, further degradation was only noted in the Taunton River system. Percentages were 14% at Day 14 and decreased to 5.8% by Day 100. Linear regression of the data suggests a total system half-life of about 65days for Met 7. No trend in the percentage of Met 7 was observed in the Wewantic River system.

Proposed structures for observed major degradates Met 1 and Met 7 were determined by LC-MS/MS. A proposed transformation pathway for [14C] letermovir was determined based on these proposed structures and HPLC-RAM analysis as presented below. Met 1 is proposed to be formed by dealkyation and then acetylation at the N proximate to the quinazoline moiety in letermovir. Met 7 is proposed to be formed by demethylation at the anisole moiety in letermovir.


Justification of chosen biotic degradation phrase:

Since half-life ≤ 120 days for total system, letermovir is slowly degraded in the environment.


Partitioning coefficient (OECD 107) (Ref.VII): 

Log Kow = 2.29 at pH 7

Justification of chosen bioaccumulation phrase:

Since log Kow < 4, letermovir has low potential for bioaccumulation.


  1. ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm

  2. Smithers Viscient, 2014. "Letermovir − 72-Hour Toxicity Test with the Freshwater Green Alga, Pseudokirchneriella subcapitata, Following OECD Guideline 201", Smithers Viscient, Wareham, MA, USA; Report 359.6857, 15 Jan 2015.

  3. Smithers Viscient, 2015. "MK-8228 – Full Life-Cycle Toxicity Test with Water Fleas, Daphnia magna, Under Static Renewal Conditions Following OECD Guideline #211", Smithers Viscient, Wareham, MA, USA; Report 359.6925, 23 December 2015.

  4. Smithers Viscient, 2016. "MK-8228 – Early Life-Stage Toxicity Test with Fathead Minnow (Pimephales promelas)", Smithers Viscient, Wareham, MA, USA; Report 359.6924, 07 March 2016.

  5. Smithers Viscient, 2016. "[14C]MK-8228 – Determination of the Biodegradability of a Test Substance in Activated Sludge Based on OECD Method 314B", Smithers Viscient, Wareham, MA, USA; Report 359.6929, 06 April 2016.

  6. Smithers Viscient, 2016. "MK-8228 - Aerobic Transformation in Aquatic Sediment Systems Following OECD Guideline 308", Smithers Viscient, Wareham, MA, USA; Report 359.6928, 10 June 2016.

  7. Smithers Viscient, 2016. "MK-8228 - Determining the Partitioning Coefficient (nOctanol/Water) by the Shake-Flask Method Following OECD Guideline 107", Smithers Viscient, Wareham, MA, USA; Report 359.6922, 27 January 2016.